loading
Genenta Science Spa Adr stock is traded at $4.75, with a volume of 8,421. It is down -10.38% in the last 24 hours and up +7.95% over the past month. Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
See More
Previous Close:
$5.30
Open:
$5.255
24h Volume:
8,421
Relative Volume:
0.66
Market Cap:
$93.28M
Revenue:
-
Net Income/Loss:
$-12.63M
P/E Ratio:
-9.8794
EPS:
-0.4808
Net Cash Flow:
$-12.18M
1W Performance:
-11.21%
1M Performance:
+7.95%
6M Performance:
+36.77%
1Y Performance:
-12.23%
1-Day Range:
Value
$4.75
$5.255
1-Week Range:
Value
$4.75
$5.49
52-Week Range:
Value
$2.20
$7.28

Genenta Science Spa Adr Stock (GNTA) Company Profile

Name
Name
Genenta Science Spa Adr
Name
Phone
-
Name
Address
-
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
GNTA's Discussions on Twitter

Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-29-23 Resumed ROTH MKM Buy
Jul-25-22 Initiated H.C. Wainwright Buy
Jan-13-22 Initiated Maxim Group Buy

Genenta Science Spa Adr Stock (GNTA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):